Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carina Peres

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Virological Methods|September 12, 2019
Flow cytometric methodology for the detection of de novo human T-cell leukemia virus -1 infection in vitro: A tool to study novel infection inhibitorsCarina Peres, Yuetsu Tanaka, Fabiola Martin, et al.
Current Topics in Medicinal Chemistry|July 2, 2015
Translational Peptide-associated Nanosystems: Promising Role as Cancer VaccinesEva Zupančič, Carina Peres, Ana I Matos, et al.
Biochemical and Biophysical Research Communications|August 12, 2015
Regulatory aspects on nanomedicinesVanessa Sainz, João Conniot, Ana I Matos, et al.
Acta Biomaterialia|November 10, 2016
Poly(lactic acid)-based particulate systems are promising tools for immune modulationCarina Peres, Ana I Matos, João Conniot, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant <i>Mycobacterium tuberculosis</i>David Pires, Manoj Mandal, Ana I Matos, et al.
Seminars in Immunology|September 25, 2017
Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activationAna Luísa Silva, Carina Peres, João Conniot, et al.
Advanced Drug Delivery Reviews|March 12, 2021
Preclinical models and technologies to advance nanovaccine developmentCarina Peres, Ana I Matos, Liane I F Moura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 22, 2019
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancerAna I Matos, Barbara Carreira, Carina Peres, et al.
Acta Biomaterialia|June 26, 2018
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanomaVanessa Sainz, Liane I F Moura, Carina Peres, et al.
Nature Nanotechnology|August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulatorsJoão Conniot, Anna Scomparin, Carina Peres, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Virological Methods|September 12, 2019
Flow cytometric methodology for the detection of de novo human T-cell leukemia virus -1 infection in vitro: A tool to study novel infection inhibitorsCarina Peres, Yuetsu Tanaka, Fabiola Martin, et al.
Current Topics in Medicinal Chemistry|July 2, 2015
Translational Peptide-associated Nanosystems: Promising Role as Cancer VaccinesEva Zupančič, Carina Peres, Ana I Matos, et al.
Biochemical and Biophysical Research Communications|August 12, 2015
Regulatory aspects on nanomedicinesVanessa Sainz, João Conniot, Ana I Matos, et al.
Acta Biomaterialia|November 10, 2016
Poly(lactic acid)-based particulate systems are promising tools for immune modulationCarina Peres, Ana I Matos, João Conniot, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant <i>Mycobacterium tuberculosis</i>David Pires, Manoj Mandal, Ana I Matos, et al.
Seminars in Immunology|September 25, 2017
Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activationAna Luísa Silva, Carina Peres, João Conniot, et al.
Advanced Drug Delivery Reviews|March 12, 2021
Preclinical models and technologies to advance nanovaccine developmentCarina Peres, Ana I Matos, Liane I F Moura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 22, 2019
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancerAna I Matos, Barbara Carreira, Carina Peres, et al.
Acta Biomaterialia|June 26, 2018
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanomaVanessa Sainz, Liane I F Moura, Carina Peres, et al.
Nature Nanotechnology|August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulatorsJoão Conniot, Anna Scomparin, Carina Peres, et al.
Pageof 2